Empowered Funds LLC Makes New $5.04 Million Investment in Teladoc Health, Inc. $TDOC

Empowered Funds LLC bought a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 578,689 shares of the health services provider’s stock, valued at approximately $5,040,000. Empowered Funds LLC owned approximately 0.33% of Teladoc Health as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Chiron Capital Management LLC raised its stake in Teladoc Health by 19.2% in the 2nd quarter. Chiron Capital Management LLC now owns 78,105 shares of the health services provider’s stock worth $680,000 after purchasing an additional 12,600 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. raised its position in shares of Teladoc Health by 23.1% in the second quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 212,933 shares of the health services provider’s stock valued at $1,841,000 after buying an additional 39,956 shares in the last quarter. Police & Firemen s Retirement System of New Jersey boosted its stake in shares of Teladoc Health by 10.0% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 40,844 shares of the health services provider’s stock valued at $356,000 after buying an additional 3,713 shares during the period. Geode Capital Management LLC grew its position in Teladoc Health by 2.1% during the second quarter. Geode Capital Management LLC now owns 4,150,197 shares of the health services provider’s stock worth $36,153,000 after buying an additional 84,356 shares in the last quarter. Finally, Vise Technologies Inc. bought a new position in Teladoc Health during the 2nd quarter worth $241,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on TDOC shares. Zacks Research downgraded Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Evercore ISI dropped their price target on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research note on Thursday, October 30th. Mizuho assumed coverage on shares of Teladoc Health in a research note on Friday, July 25th. They set a “neutral” rating and a $10.00 price objective on the stock. Citigroup raised their target price on shares of Teladoc Health from $9.50 to $10.50 and gave the company a “neutral” rating in a report on Tuesday, October 21st. Finally, BMO Capital Markets started coverage on shares of Teladoc Health in a report on Thursday, November 13th. They set a “market perform” rating and a $8.00 price target for the company. Five investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $9.61.

Teladoc Health Trading Up 2.7%

TDOC opened at $6.94 on Friday. The company’s 50 day moving average is $8.12 and its 200-day moving average is $7.74. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21. The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71. The company has a market cap of $1.23 billion, a P/E ratio of -5.42 and a beta of 1.92.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. The business had revenue of $626.44 million during the quarter, compared to analysts’ expectations of $625.66 million. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The firm’s quarterly revenue was down 2.2% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.19) EPS. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Equities research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.